|
|
||||||||
|
Interact CardioVasc Thorac Surg 2006;5:25-26. doi:10.1510/icvts.2005.118885 © 2006 European Association of Cardio-Thoracic Surgery
Fatal anaphylactoid reaction after primary exposure to aprotininDepartment of Cardiac Surgery, Virgen de la Salud Hospital, Avda. Barber, 30, 45004 Toledo, Spain
*Corresponding author. Tel.: +34-925-269200; fax: +34-925-214860. Aprotinin is widely used to prevent bleeding, inhibit systemic inflammatory response and reduce blood transfusions after cardiac surgery. Because it is a bovine protein, aprotinin can induce hypersensitivity reactions. We report a case of fatal anaphylactoid reaction to primary aprotinin exposure in a woman who was admitted for mitral valve replacement. The possibility of anaphylactic reaction should be considered whenever aprotinin is used.
Key Words: Surgery complications; Surgery emergency; Resuscitation This article has been cited by other articles:
|
||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |